[국제]AstraZeneca vaccine contracted for pre-purchase in Korea…”approved in the UK within 10 days”

[앵커]

The AstraZeneca Corona 19 vaccine, which Korea pre-purchased a dose of 10 million people, is expected to be approved for emergency use in the UK within 10 days.

If group vaccination begins in the UK in early January next year, it is expected that the vaccination will begin in earnest after approval procedures in Korea, the US, and Japan.

Reporter Kim Hyung-geun on the report.

[기자]

“The Corona 19 vaccine developed by Oxford University in the UK and pharmaceutical company AstraZeneca may be approved for emergency use from 28 to 29 this month.”

The British Daily Telegraph reported this, citing a senior British government source.

If Oxford University submits the relevant data around the 21st, the UK Drug and Health Care Products Regulatory Authority will approve emergency use around the 28th and 29th.

The UK government plans to enter the vaccination on a large scale starting in early January next year once approved for use.

AstraZeneca vaccine has been delayed in application for approval as a reliability issue has been raised in the results of phase 3 clinical trials.

However, it is being evaluated as the most advantageous in the future Corona 19 vaccine competition.

Telegraph predicted that the AstraZeneca vaccine will become a’game changer’ that changes the COVID-19 phase.

Unlike Pfizer, modders and vaccines that must be distributed at cryogenic temperatures, it is absolutely advantageous for distribution and distribution because it can be stored refrigerated.

In addition, the price is 5 to 10 times cheaper than Pfizer, modder or vaccine.

In addition, it is known to be advantageous for mass production.

[조나단 반탐 / 영국 보건부 자문위원 : 저는 이 백신이 보급 용이성과 접근성 측면에서 진정한 글로벌 백신이 될 것이라고 생각합니다. 그리고 저소득 국가나 중위 소득 국가에 대해서는 다른 백신보다 더 저렴하게 공급될 것입니다.]

Because of this, major countries in the United States and Europe also bought more AstraZeneca vaccines than Pfizer, Modena, or vaccines.

The Korean government has also signed a contract to supply 10 million doses.

In particular, in Korea, SK Bioscience is consigning production of AstraZeneca vaccines.

Therefore, the news of the imminent approval of the AstraZeneca vaccine is good news for Korea, which is waiting for the vaccine supply.

This is YTN Kim Hyung-geun.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

– .